News archive
INVITATION TO LIVE Q&A, REGARDING PRECLINICAL STUDIES AND UPCOMING CLINICAL STUDIES [January 27, 2026]
PILA PHARMA AB (publ) (FN STO: PILA) (“PILA PHARMA” or the “Company”), an innovative biotech company developing a novel oral, small molecule TRPV1 inhibitor, today hosts an online Q&A (questions and answers) in relation to its concluded preclinical studies and upcoming clinical activities.
[January 12–14, 2026]
Biotech Showcase, JP Morgan Healthcare Week, San Francisco, United States.
[PILA PHARMA Corporate Presentation Tuesday, Jan 13 at 11:30AM PT]
[November 27, 2025]
Aktiespararna Stora Aktiedagarna
[November 26, 2025]
Økonomisk Ugebrev Life Science.
[November 25, 2025]
Aktielnfo Kolding.
[November 24, 2025]
AktieInfo Aalborg.
[November 17, 2025]
Dansk Aktionærforening “Investordagen 2025”.
[November 7–10, 2025]
American Heart Association Convention – New Orleans, United States.
[November 4-7, 2025]
ObesityWeek – Atlanta, United States (in-person)
Dansk Aktionærforening – Mød selskabet Live. Fredericia, Danmark.
[September 24, 2025]
EASD Congress in Vienna, Austria
[September 16–19, 2025]
Aktiespararna Falkenberg – Company Presentation
[September 9, 2025]
The CEO of Pila Pharma was recently interviewed by Vækstaktier, Denmark about his participation in BIO INTERNATIONAL CONVENTION 2024, the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with over 20,000 industry leaders from across the globe.
Find the link to the article and other articles about Pila Pharma (in Danish) on Vækstaktier.dk
Read the report (in English) here
Read the report PDF (in Danish) here
Read the report (in Swedish) here
2. analyse – Pila Pharma Halvårsrapport 2024 (September 30, 2024)
Read the report PDF (in Danish) here
Millionærklubben by EuroInvestor [14. November 2024]
CEO Gustav H. Gram participates in Denmark’s largest finance and investment podcast to elaborate on PILA PHARMA and discuss the emerging trends within the obesity and diabetes market.
Please, find the link to the video (in Danish) here
PILA PHARMA PUBLISHES THE ANNUAL REPORT 2024
The report in Swedish can be found here
